Redx Pharma PLC £25.5m Raise To Drive Forward Key Programmes Discussion Transcript
Hello, there. You're watching Proactive London. And joining us today, we have Lisa Anson here from Redx Pharma, the drug discovery and development company, focused on cancer and fibrosis. Hello to you, Lisa?
Hi, [Casey], nice to see you.
Questions & Answers
Nice to see you. It's our first introduction here at Proactive, so plenty to discuss. But first of all, you've had a massive week because you've had this conditional raising of GBP 25.5 million. So I guess the question has to be, what are the plans now?
Yes. It's a very exciting announcement for us, the conditional raise that we announced this week and also the open offer. So this puts us in a much stronger financial position, which allows us really to drive forward our 2 key programs, 1 of which is in the clinic, 1 of which about to go into
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |